FDA Articles | FDA Letter | FDA Advice | FDA Process  
  SEARCH: Sign In | Register | Contact Us | Site Map | Home  

Resources for Food and Drug Administration (FDA)

Resources > FDA > Articles

Sub-Categories:

Listings 411 - 420 of 2187:

FDA Advisers Reject Over-the-Counter Statin
For the third time in seven years, U.S. Food and Drug Administration advisers have voted to deny Merck & Co.'s request to make the cholesterol-loweri...
FDA advisers set vaccine for 2009-2010 flu season
Government medical advisers on Wednesday issued their recommendations for next season's flu vaccine, the front line defense against a disease that kil...
FDA Advises Consumers: Avoid Eating Maine Lobster Tomalley
The U.S. Food and Drug Administration (FDA) on Monday advised consumers against eating tomalley or liver in lobsters after it was found to be contamin...
FDA advises doctors to limit heparin doses
U.S. regulators have urged doctors to limit use of Baxter International Inc.'s blood thinner heparin after getting reports of severe reactions among ...
FDA advisors must abide by new financial limits
Outside experts may not participate in federal advisory committee meetings on drugs and medical devices if they have more than a $50,000 financial int...
FDA Advisory Committee Recommends GTC Biotherapeutics' ATryn
GTC Biotherapeutics ("GTC", NASDAQ: GTCB) and OVATION Pharmaceuticals, Inc. announced today that the Blood Products Advisory Committee of the U.S. Foo...
FDA Advisory Committees Oppose OTC Status For Statins
wo Food and Drug Administration advisory committees recommended that the agency not approve over-the-counter status for lovastatin 20 mg (Mevacor). ...
FDA advisory panel questions agency ruling on BPA
The Food and Drug Administration’s Science Board has strongly criticized the agency’s recent ruling that the chemical Bisphenol-A (BPA) is safe. The p...
FDA Advisory Panel to Vote on Approval of Prasugrel
An FDA advisory committee is expected to endorse prasugrel (Effient) for preventing thrombosis in high-risk acute coronary syndrome patients who under...
FDA Agent Faults Sanofi-Aventis for Ketek Trial Troubles
Just when you think it’s all Vytorin all the time in Congress, they change things up a bit. Michigan Democrats John Dingell and Bart Stupak took a Vyt...


Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 Next

  Search this category:




Google
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home
Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved.